Edward F. Heimers
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von Edward F. Heimers
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.
23
| Subsidiary | Pharmaceuticals: Major | 23 |
Sandoz Pharmaceuticals Corp.
12
| Subsidiary | 12 | |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Innovex LP is a company that provides contract product development services. The company is based in Durham, NC.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Edward F. Heimers
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel Director of Finance/CFO Corporate Officer/Principal | |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Pulmatrix Operating Co., Inc.
 Pulmatrix Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Pulmatrix Operating Co., Inc. develops pharmaceutical products for respiratory infectious diseases. Its iSPERSE powders can be used with an array of dry powder inhaler technologies and can be formulated with virtually any drug substance. The company was founded by David Alan Edwards, Mark J. Gabrielson, Alexander M. Klibanov and Robert S. Langer in 2003 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SANOFI INDIA LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Chief Executive Officer Chairman Corporate Officer/Principal | |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal | |
| State University of New York College at Oneonta | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Undergraduate Degree Masters Business Admin Graduate Degree Doctorate Degree | |
| University of Arizona | College/University | Doctorate Degree | |
| University of Vermont | College/University | Doctorate Degree | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
| University of Zurich | College/University | Corporate Officer/Principal Doctorate Degree | |
| Nanjing University | College/University | Graduate Degree | |
Ambrilia Biopharma, Inc.
 Ambrilia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ambrilia Biopharma, Inc. discovers and develops novel treatments for viral diseases and cancer. Its product portfolio is comprised of oncology and antiviral assets, including two new formulations of existing peptides for cancer treatment, a targeted delivery technology for cancer, an HIV protease inhibitor program as well as HIV integrase and entry inhibitors, Hepatitis C virus inhibitors and anti-Influenza A compounds. The company was founded on November 27, 1986 and is headquartered in Montréal, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member | |
| Bryant University | College/University | Masters Business Admin Undergraduate Degree | |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director/Board Member | |
Ascletis Biopharmaceutical (Hangzhou) Co. Ltd.
 Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. Medical SpecialtiesHealth Technology Ascletis Biopharmaceutical (Hangzhou) Co. Ltd. engages in discovering and developing new treatments for cancer and infectious diseases. The firm is currently developing ALN-VSP, a systemically delivered RNAi therapeutic comprising of two siRNAs designed to target two genes critical for the growth and development of cancer cells. It provides services to the Chinese pharmaceutical markets. The company was founded by Jinxing Qi and Jinzi J. Wu in 2011 and is headquartered in Hangzhou, China. | Medical Specialties | Chief Executive Officer | |
| The BayHelix Group | Corporate Officer/Principal | ||
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director/Board Member | |
| AURINIA PHARMACEUTICALS INC. | Biotechnology | Chief Executive Officer | |
| VIKING THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Financial Executives International Philadelphia Chapter | Director/Board Member | ||
| PULMATRIX, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Director/Board Member | |
| ASCLETIS PHARMA INC. | Biotechnology | Chief Executive Officer | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| Ascletis BioScience Co., Ltd. | Chief Executive Officer | ||
| SATELLOS BIOSCIENCE INC. | Pharmaceuticals: Major | Director/Board Member | |
| Ascletis Pharma China Co., Ltd. | Director/Board Member | ||
| Ascletis Xinnuo Medicine Co., Ltd | Chief Executive Officer | ||
| Soundridge Pharmaceuticals (Hong Kong) Co., Ltd. | Director/Board Member | ||
| Ascletis Pharmaceuticals Co., Ltd. | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 30 |
| China | 7 |
| Vereinigtes Königreich | 6 |
| Kanada | 4 |
| Schweiz | 3 |
Sektoral
| Health Technology | 34 |
| Consumer Services | 8 |
| Technology Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 190 |
| Corporate Officer/Principal | 106 |
| Independent Dir/Board Member | 58 |
| Chairman | 54 |
| President | 44 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Philippe Chambon | 31 |
| Wayne P. Yetter | 28 |
| Michael Perry | 28 |
| Thomas Paul Koestler | 26 |
| Mark Iwicki | 26 |
| Charles Rowland | 25 |
| Daniel Vasella | 25 |
| Timothy Rothwell | 24 |
| Mark A. Pulido | 23 |
| Lawrence Olanoff | 22 |
| Jinzi Wu | 20 |
| Kurt Graves | 15 |
| Gilles Gagnon | 15 |
| Georgia Keresty | 15 |
| Geoffrey Nichol | 14 |
- Börse
- Insiders
- Edward F. Heimers
- Unternehmensverbindungen
